Phathom Pharmaceuticals on the Verge of Breakthrough – Revenue Explodes and Profitability Within Reach

Phathom Pharmaceuticals is a US-based biopharmaceutical company specializing in the development and marketing of innovative therapies for gastrointestinal diseases. At the center of its focus is the active ingredient Vonoprazan, a modern acid blocker considered an alternative to classic proton pump inhibitors, especially used for reflux diseases and Helicobacter pylori infections. The business model is based on the successful commercialization of these products, with increasing prescription numbers and growing market penetration serving as the central...